This observation insinuates that miRNAs contribute to the development and metastasis of tumors in MTC, and the fact that biological processes such as the TGFβ signaling pathway can be regarded as novel therapeutic targets in metastatic MTC [48]. This evidence concerns the gene TGFB1 and medullary thyroid gland carcinoma.